Showing results (111-120 of 760) with videos related to
Sort By:
Pageof 76
Expert Review of Anticancer Therapy|August 24, 2006
Lenalidomide in multiple myelomaPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.Expert Opinion on Investigational Drugs|October 10, 2007
The therapeutic role of targeting protein kinase C in solid and hematologic malignanciesKlaus Podar, Marc S Raab, Dharminder Chauhan, et al.Annual Review of Medicine|January 18, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.Current Pharmaceutical Biotechnology|November 2, 2006
Recent advances in the treatment of Multiple MyelomaHiroshi Yasui, Teru Hideshima, Paul G Richardson, et al.Nature Reviews. Clinical Oncology|January 10, 2018
The bone-marrow niche in MDS and MGUS: implications for AML and MMIrene M Ghobrial, Alexandre Detappe, Kenneth C Anderson, et al.Cell Cycle (Georgetown, Tex.)|October 7, 2004
Mcl-1 regulation and its role in multiple myelomaSteven Le Gouill, Klaus Podar, Jean-Luc Harousseau, et al.British Journal of Haematology|May 12, 2018
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myelomaCindy Varga, Jacob P Laubach, Kenneth C Anderson, et al.Clinical Pharmacology : Advances and Applications|August 26, 2021
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and SelinexorNisha S Joseph, Yu-Tzu Tai, Kenneth C Anderson, et al.Seminars in Oncology|April 30, 2003
Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasiasConstantine S Mitsiades, Nicholas Mitsiades, Steven P Treon, et al.Best Practice & Research. Clinical Haematology|July 20, 2005
Novel biological therapies for the treatment of multiple myelomaPaul G Richardson, Constantine S Mitsiades, Teru Hideshima, et al.Pageof 76